Do blood transfusions help at the end of life? a study asks patients and staff

NCT ID NCT06786897

Ongoing Knowledge-focused Sponsor: University Hospital, Montpellier Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how patients with advanced blood cancers (like acute myeloid leukemia) who are not eligible for a cure, along with their nurses and doctors, feel about the benefits of blood transfusions. Researchers will give questionnaires before each transfusion to compare expectations. The goal is to better understand when transfusions truly help maintain quality of life in palliative care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors and patients make more informed decisions about when blood transfusions are truly beneficial in palliative care.
What could go wrong: This is a small observational study that measures opinions, not outcomes. It may not change clinical practice or prove that transfusions help or harm.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute lymphoblastic leukemia acute myeloid leukemia blast phase chronic myelogenous leukemia, BCR-ABL1 positive myelodysplastic syndrome primary myelofibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE MYELOID LEUKEMIA

Contacts and locations

Locations

UH Montpellier

Montpellier, 34000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.